Skip to content

Clinical trials

Fibrosis trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Country / region: Singapore Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20091
20181
20211
20222
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Changi General Hospital2
Novartis Pharmaceuticals2
Chinese University of Hong Kong1
GlaxoSmithKline1
Singapore General Hospital1
Stem Med Pte. Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis10
Liver Cirrhosis3
Liver Diseases3
Digestive System Diseases2
Fatty Liver2
Hepatitis B, Chronic2
Metabolic Diseases2
Non-alcoholic Fatty Liver Disease2
Acute-On-Chronic Liver Failure1
Death1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.